|1.||Mermin, Jonathan: 12 articles (04/2012 - 10/2004)|
|2.||Raoult, Didier: 11 articles (01/2015 - 03/2002)|
|3.||Dorsey, Grant: 10 articles (12/2014 - 09/2006)|
|4.||Walker, A Sarah: 9 articles (03/2015 - 01/2007)|
|5.||Kamya, Moses R: 9 articles (12/2014 - 10/2007)|
|6.||Anglaret, Xavier: 8 articles (04/2015 - 01/2005)|
|7.||Juurlink, David N: 8 articles (03/2015 - 04/2003)|
|8.||Gibb, Diana M: 8 articles (03/2015 - 01/2007)|
|9.||Gupta, Kalpana: 8 articles (10/2014 - 07/2002)|
|10.||Tappero, Jordan W: 7 articles (12/2014 - 10/2010)|
01/01/1998 - "Modern treatment options, including prophylaxis with trimethoprim-sulfamethoxazole and rIFN-gamma as well as early and aggressive anti-infection therapy, have improved the prognosis of this disease dramatically. "
01/01/2003 - "The infection was treated successfully with trimethoprim-sulfamethoxazole. "
01/01/1998 - "Cyclospora infections can be treated successfully with trimethoprim-sulfamethoxazole."
02/01/1989 - "The exclusive use of TMP/SMX produced a significant reduction in mortality (P less than 0.0001) and an absence of clinical signs of infection. "
05/01/1982 - "These data indicated that a mean dose of TMP/SMX 6.8/34 mg/kg/d divided into twice daily doses and given for six months was safe and effective in controlling RAOM infections in a high-risk pediatric population."
|2.||Urinary Tract Infections (Urinary Tract Infection)
08/08/1990 - "In over 6 months of observation, postcoital administration of trimethoprim-sulfamethoxazole was highly effective in preventing recurrent urinary tract infections. "
06/01/1985 - "Single-dose trimethoprim-sulfamethoxazole is as effective as ten-day treatment in women with symptoms suggestive of lower urinary tract infection and has no greater relapse rate."
01/01/2001 - "The aim of the study was to determine the efficacy of cotrimoxazole administration after urodynamic testing to prevent urinary tract infections. "
06/01/1988 - "Efficacy of five years of continuous, low-dose trimethoprim-sulfamethoxazole prophylaxis for urinary tract infection."
07/01/1981 - "The efficacy of a long-term prophylaxis with Co-trimoxazole was studied in 18 girls with recurrent urinary tract infections. "
01/01/2006 - "Cotrimoxazole is cheap and effective against a wide range of organisms, including Pneumocystis jiroveci pneumonia (PCP), which is an important cause of death and illness in the first year of life. "
11/21/2001 - "Chemotherapeutic prophylaxis is very effective in preventing P carinii pneumonia; the combination of trimethoprim-sulfamethoxazole remains the first-line agent for both therapy and prophylaxis. "
01/01/1984 - "Trimethoprim sulfamethoxazole is very effective in the prevention of Pneumocystis carinii pneumonitis. "
09/01/1979 - "Trimethoprim-sulfamethoxazole has been proven effective in the treatment and prevention of Pneumocystis carinii pneumonitis in lower animals and humans. "
01/01/2005 - "Both standard and double strength cotrimoxazole were equally effective in treating non-severe pneumonia. "
|4.||Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
11/01/1993 - "Trimethoprim-sulfamethoxazole administered orally daily or thrice weekly is highly effective for the prevention of Pneumocystis carinii pneumonia. "
01/01/2003 - "Cotrimoxazole is cheap and effective against a wide range of organisms, including Pneumocystis carinii pneumonia (PCP) which is an important cause of death and illness in the first year of life. "
10/01/2005 - "Prevention and treatment of Pneumocystis pneumonia with trimethoprim/sulfamethoxazole is effective in reducing this risk. "
07/01/1994 - "This preliminary study suggests that the efficacy of these regimens in preventing pneumocystis pneumonia, however, may be less than that of trimethoprim-sulfamethoxazole."
10/01/2003 - "Although several studies have reported that it is safe to discontinue secondary Pneumocystis carinii pneumonia (PCP) prophylaxis in patients infected with HIV who experience a sustained immune response as a result of antiretroviral therapy, we describe a patient who developed recurrent PCP <3 months after discontinuing trimethoprim-sulfamethoxazole prophylaxis. "
01/01/2011 - "Co-trimoxazole prophylaxis was moderately protective against malaria in HIV exposed infants when continued beyond the period of HIV exposure despite the high prevalence of Plasmodium genotypes associated with antifolate resistance. "
10/01/2007 - "The efficacy of TMP/SMX may be diminished where antifolate resistance to malaria is high. "
12/01/2014 - "Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial."
01/01/2015 - "Cotrimoxazole prophylaxis was strongly protective against the incidence of malaria when associated with ART in HIV-infected children. "
01/01/2011 - "To evaluate the protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children (uninfected children born to HIV infected mothers) in Africa. "
|1.||Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)
|3.||Thymidine Monophosphate (TMP)
|9.||Anti-Bacterial Agents (Antibiotics)
|3.||Drug Therapy (Chemotherapy)
|4.||Transplantation (Transplant Recipients)